Ing Groep Nv Horizon Therapeutics Public LTD CO Transaction History

Ing Groep Nv

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$98.98 - $115.74 $8.51 Million - $9.95 Million	86,000 Added 31.3%	360,725 $41.7 Million
Q2 2023 Aug 07, 2023	BUY	$96.34 - $112.38 $11.8 Million - $13.8 Million	122,413 Added 80.37%	274,725 $28.3 Million
Q1 2023 May 09, 2023	BUY	$107.32 - $113.5 $16.3 Million - $17.3 Million	152,312 New	152,312 $16.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.